









Markets
/
Stocks
/
nasdaq-smlr
/

Semler Scientific Inc

SMLR

20.330USD

0.0000.00%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

307.84MMarket Cap

3.65P/E TTM



Semler Scientific Inc

20.330

0.0000.00%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Semler Scientific Inc

Currency: USD Updated: 2026-01-15

Key Insights

Semler Scientific Inc's fundamentals are relatively stable, with low ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 111 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 65.67.In the medium term, the stock price is expected to trend down.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Semler Scientific Inc's Score

Industry at a Glance

Industry Ranking

111 / 206

Overall Ranking

253 / 4555

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Semler Scientific Inc Highlights

StrengthsRisks

Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.

Growing

The company is in a growing phase, with the latest annual income totaling USD 56.29M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 56.29M.

Undervalued

The company’s latest PE is 3.65, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 10.05M shares, decreasing 27.59% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 31.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.24.

Analyst Rating

Based on 0 analysts

Current Rating

73.000

Target Price

+259.08%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-15

Its latest quarterly revenue reached 7.49M, representing a year-over-year decrease of 44.56%, while its net profit experienced a year-over-year decrease of 201.34%.

Score

Industry at a Glance

Previous score

5.15

Change



Financials

5.88

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

4.79

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.83

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.19

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Semler Scientific Inc's Company Valuation

Currency: USD Updated: 2026-01-15

The current valuation score of Semler Scientific Inc is 6.18, ranking 170 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 3.65, which is 789.80% below the recent high of 32.52 and 725.30% above the recent low of -22.85.

Score

Industry at a Glance

Previous score

6.18

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 111/206

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-15

The current earnings forecast score of Semler Scientific Inc is 8.00, ranking 60 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 60.00, with a high of 86.00 and a low of 51.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-15

The current price momentum score of Semler Scientific Inc is 8.87, ranking 52 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 24.72 and the support level at 15.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.05

Change

-0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.986

Neutral

RSI(14)

52.280

Neutral

STOCH(KDJ)(9,3,3)

48.484

Sell

ATR(14)

2.125

High Vlolatility

CCI(14)

45.155

Neutral

Williams %R

41.473

Buy

TRIX(12,20)

0.344

Sell

StochRSI(14)

13.513

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

20.784

Sell

MA10

20.537

Sell

MA20

18.579

Buy

MA50

20.382

Sell

MA100

24.236

Sell

MA200

30.344

Sell

Institutional Confidence

Currency: USD Updated: 2026-01-15

The latest institutional shareholding proportion is 62.87%, representing a quarter-over-quarter decrease of 16.16%. The largest institutional shareholder is The Vanguard, holding a total of 700.50K shares, representing 4.58% of shares outstanding, with 15.96% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Interchange Capital Partners LLC

1.27M

-1.30%

Morgan Stanley Investment Management Inc. (US)

885.11K

+12.99%

BlackRock Institutional Trust Company, N.A.

796.25K

+36.82%

The Vanguard Group, Inc.

Star Investors

700.50K

+9.54%

Citadel Advisors LLC

403.27K

-34.67%

Charles Schwab Investment Management, Inc.

396.06K

+123.57%

Capital International Investors

385.24K

-44.73%

Morgan Stanley Smith Barney LLC

307.94K

-17.85%

Geode Capital Management, L.L.C.

300.26K

+39.59%

Risk Assessment

Currency: USD Updated: 2026-01-15

Semler Scientific Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.